Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Med. intensiva (Madr., Ed. impr.) ; 40(2): 90-95, mar. 2016. graf, tab
Artigo em Espanhol | IBECS | ID: ibc-151107

RESUMO

OBJETIVOS: El objetivo de este estudio es medir la accesibilidad al sistema sanitario de los pacientes diabéticos y analizar si las posibles diferencias en la accesibilidad explican la mayor mortalidad conocida en aquellos. MÉTODOS: Estudio de cohortes retrospectivo, realizado en pacientes diabéticos con síndrome coronario agudo con elevación del segmento ST incluidos en los años 2010 al 2013 del registro ARIAM-SEMICYUC. Se realiza análisis crudo y ajustado mediante regresión logística no condicional. RESULTADOS: Se han analizado 4817 pacientes, de los cuales 1070 (22,2%) son diabéticos. Los pacientes diabéticos contactan con el sistema sanitario de la misma forma que los pacientes no diabéticos aunque con mayor retraso (retraso atribuible al paciente 90 min vs. 75 min con p = 0,004 y retraso prehospitalario 150 min vs. 130 min con p = 0,002). Una vez dentro del sistema sanitario, estos pacientes tienen menor tasa de reperfusión (50 vs. 57,7%; p < 0,001) pero sin objetivar mayor retraso en el tratamiento. Como ya es conocido, los pacientes diabéticos presentan una mayor mortalidad hospitalaria (12,5 vs. 6%; p < 0,001); sin embargo, no se identifican como variables predictoras independientes de la mortalidad ni el retraso atribuible al paciente ni el retraso prehospitalario. CONCLUSIONES: Los pacientes diabéticos tienen una mayor demora en el acceso al sistema sanitario, sin embargo no hemos podido objetivar que esta demora se relacione de forma independiente con la mayor mortalidad


OBJECTIVES: To measure accessibility to health care among diabetic patients and analyze whether differences in delay explain differences in hospital mortality. METHODS: A retrospective cohort study was conducted in diabetic patients with acute coronary syndrome with ST-segment elevation included in the ARIAM-SEMICYUC registry (2010-2013). Crude and adjusted analyses were performed using unconditional logistic regression. RESULTS: A total of 4817 patients were analyzed, of whom 1070 (22.2%) were diabetics. No differences were found in access to health care between diabetic and non-diabetic patients. Diabetic patients presented with longer patient delay (90 min vs. 75 min; p = .004) and prehospital delay (150min vs. 130 min; p = .002). Once the health system was contacted, diabetic patients had a lower reperfusion rate (50% vs. 57.7%; p < .001), but no longer delay in treatment was observed compared with the non-diabetic individuals. Diabetic patients have greater in-hospital mortality (12.5 vs. 6%; p < .001), though neither patient delay nor prehospital delay were identified as independent predictors of in-hospital mortality. CONCLUSIONS: Diabetic patients had a longer delay in access to health care, though such delay was not independently related to increased mortality


Assuntos
Humanos , Diabetes Mellitus/epidemiologia , Síndrome Coronariana Aguda/epidemiologia , Acesso aos Serviços de Saúde/estatística & dados numéricos , Estudos Retrospectivos , Modelos Logísticos
2.
Med Intensiva ; 40(2): 90-5, 2016 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-26008217

RESUMO

OBJECTIVES: To measure accessibility to health care among diabetic patients and analyze whether differences in delay explain differences in hospital mortality. METHODS: A retrospective cohort study was conducted in diabetic patients with acute coronary syndrome with ST-segment elevation included in the ARIAM-SEMICYUC registry (2010-2013). Crude and adjusted analyses were performed using unconditional logistic regression. RESULTS: A total of 4817 patients were analyzed, of whom 1070 (22.2%) were diabetics. No differences were found in access to health care between diabetic and non-diabetic patients. Diabetic patients presented with longer patient delay (90 min vs. 75 min; p=.004) and prehospital delay (150 min vs. 130 min; p=.002). Once the health system was contacted, diabetic patients had a lower reperfusion rate (50% vs. 57.7%; p<.001), but no longer delay in treatment was observed compared with the non-diabetic individuals. Diabetic patients have greater in-hospital mortality (12.5 vs. 6%; p <.001), though neither patient delay nor prehospital delay were identified as independent predictors of in-hospital mortality. CONCLUSIONS: Diabetic patients had a longer delay in access to health care, though such delay was not independently related to increased mortality.


Assuntos
Síndrome Coronariana Aguda/terapia , Diabetes Mellitus , Acesso aos Serviços de Saúde , Estudos de Coortes , Eletrocardiografia , Mortalidade Hospitalar , Humanos , Infarto do Miocárdio , Estudos Retrospectivos
3.
Emergencias (St. Vicenç dels Horts) ; 23(2): 112-114, abr. 2011. ilus
Artigo em Espanhol | IBECS | ID: ibc-94170

RESUMO

Se conoce como histiocitosis a un grupo de enfermedades poco frecuentes que se caracterizan por la proliferación, reactiva o neoplásica, de determinadas células del sistema mononuclear-fagocítico, los histiocitos, como una respuesta inmunitaria anómala de forma localizada en un órgano o tejido o de forma generalizada. Actualmente, se clasifican en 3 grandes grupos: la histiocitosis de células de Langerhans (histiocitosis X); las histiocitosis de célulasfagocito-mononucleares diferentes a las células de Langerhans; y los desórdenes histiocíticosmalignos (leucemia monocítica aguda, histiocitosis maligna y linfoma histiocítico). Cuando la histiocitosis X afecta a los cuerpos vertebrales, habitualmente tras una dorsalgia o lumbalgiasubaguda, pueden aparecer déficit neurológicos agudos que hagan consultar al paciente en el servicio de urgencias (AU)


Histiocytoses form a group of rare diseases characterized by the reactive or neoplastic proliferation of histiocytes. Anabnormal immune response may cause these mononuclear phagocytes to proliferate generally or locally within an organ or tissue. These diseases are currently classified in 3 broad groups: Langerhans cell histiocytosis (histiocytosis X); non-Langerhans cell histiocytoses; and malignant histiocytic disorders (acute monocytic leukemia, malignant histiocytosis, and lymphohistiocytosis. When histiocytosis X affects vertebral bodies, usually following subacute lumbar or other backpain, acute neurologic deficits may lead the patient to seek emergency care (AU)


Assuntos
Humanos , Masculino , Adulto , Histiocitose de Células de Langerhans/complicações , Parestesia/etiologia , Dor nas Costas/etiologia , Granuloma Eosinófilo/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...